Peptides
Tirzepatide's Expanding Frontier: From Pediatric Diabetes to Liver Mitochondria
A landmark phase 3 trial puts the dual-receptor agonist on the map for adolescents with type 2 diabetes — and new mechanistic work suggests its effects reach all the way down to the mitochondrion.